Am J Physiol Cell Physiol Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Cell Physiol 292: C1672-C1680, 2007. First published November 8, 2006; doi:10.1152/ajpcell.00153.2006
0363-6143/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/5/C1672    most recent
00153.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Litvin, J.
Right arrow Articles by Autieri, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Litvin, J.
Right arrow Articles by Autieri, M.

VASCULAR BIOLOGY

Expression and function of periostin-like factor in vascular smooth muscle cells

Judith Litvin,1,3 Xing Chen,2 Sheri Keleman,3 Shimei Zhu,1 and Michael Autieri2,3

1Department of Anatomy and Cell Biology, 2Department of Physiology, and 3The Cardiovascular Center for Research, Temple University Medical School, Philadelphia, Pennsylvania

Submitted 4 April 2006 ; accepted in final form 7 November 2006

In injured blood vessels activated vascular smooth muscle cells (VSMCs) migrate from the media to the intima, proliferate and synthesize matrix proteins. This results in occlusion of the lumen and detrimental clinical manifestations. We have identified a novel isoform of the periostin family of proteins referred to as periostin-like factor (PLF). PLF expression in VSMCs was increased following treatment with mitogenic compounds, suggesting that PLF plays a role in VSMC activation. Correspondingly, proliferation of the cells was significantly reduced with anti-PLF antibody treatment. PLF expression increased VSMC migration, an essential cellular process leading to vascular restenosis after injury. PLF protein was localized to neointimal VSMC of rat and swine balloon angioplasty injured arteries, as well as in human arteries with transplant restenosis, supporting the hypothesis that PLF is involved in VSMC activation and vascular proliferative diseases. Taken together, these data suggest a role for PLF in the regulation of vascular proliferative disease.

migration; proliferation



Address for reprint requests and other correspondence: J. Litvin, Temple Univ., School of Medicine, Dept. of Anatomy and Cell Biology, 3420 N. Broad St., MRB 615, Philadelphia, PA 19140 (e-mail: judith.litvin{at}temple.edu)




This article has been cited by other articles:


Home page
Reproductive SciencesHome page
R. F. Savaris, A. E. Hamilton, B. A. Lessey, and L. C. Giudice
Endometrial Gene Expression in Early Pregnancy: Lessons From Human Ectopic Pregnancy
Reproductive Sciences, October 1, 2008; 15(8): 797 - 816.
[Abstract] [PDF]


Home page
J. Histochem. Cytochem.Home page
S. Zhu, M. F. Barbe, N. Amin, S. Rani, S. N. Popoff, F. F. Safadi, and J. Litvin
Immunolocalization of Periostin-like Factor and Periostin During Embryogenesis
J. Histochem. Cytochem., April 1, 2008; 56(4): 329 - 345.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.